“Yes! We Can End TB: Commit, Invest, Deliver” TB continues to cause immense human suffering and severe health, social, and economic consequences across the world. Every year, 10 million people…
“Yes! We Can End TB: Commit, Invest, Deliver” TB continues to cause immense human suffering and severe health, social, and economic consequences across the world. Every year, 10 million people…
Today is #WorldTBDay, a day to raise awareness about the devastating impact of #tuberculosis – one of the world’s oldest and deadliest diseases. #YesWeCanEndTB. #Archivelfarma is aligned with WHO goals…
A new clinical trial, CONSTAN-ARG, will test the effectiveness of the #RUTI® vaccine to shorten treatment in #TB patients. #Archivel Farma has designed and set up a phase IIb clinical study called CONSTAN-ARG to…
The Spanish biotech company Archivel Farma has officially begun the clinical trial of its therapeutic vaccine RUTI®, which will be carried out by Clinical Research Network India, a Contract Research…
As of 30th October 2019, Archivel Farma has obtained from the Spanish Health Authority the authorization as Manufacturer for Sterile investigational medicinal products for terminal sterilised operations of Solids and Implants…